Increased government expenditures are the only policy that would get the Eurozone out of its current quagmire. With the German emphasis on austerity, that will not happen.
The reporting cycle really accelerates this week, with almost 500 companies coming out with Q4 results, including 136 S&P 500 members.
The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. Edward Stopke of Sagient Research unveils his list of companies with catalytic moments in the making.
Over the past few weeks, oil and gasoline inventories have continued to rise despite declining gasoline production. This could be a sign of growing economic weakness.
ARRY stock popped on news that It would acquire a late-stage cancer compound known as encorafenib.
It is the busiest week for Q4 earnings reports, the economic calendar includes a flood of data as well as an FOMC meeting on Wednesday.
